ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,816.00
      -0.15%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.59
      -0.89%
      Bitcoin
      62,634.01
      -3.42%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO

      Mesoblast (MESO)

      Mesoblast Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MESO
      DateTimeSourceHeadlineSymbolCompany
      05/03/20176:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      04/13/20178:52AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      04/10/20176:00AMGlobeNewswire Inc.Successful Interim Analysis of Efficacy Endpoint in Mesoblast’s Phase 3 Trial for Chronic Heart FailureNASDAQ:MESOMesoblast Limited
      04/07/20174:01PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      04/06/20176:00AMGlobeNewswire Inc.Mesoblast Receives A$3.7 Million From the Australian Government for Research and Development ActivitiesNASDAQ:MESOMesoblast Limited
      04/03/20174:34PMGlobeNewswire Inc.FDA Clears Heart Disease Trial at Harvard's Boston Children’s Hospital Using Mesoblast's Cell Therapy to Grow Heart Muscle ...NASDAQ:MESOMesoblast Limited
      04/03/20177:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      03/31/20176:17AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      03/31/20176:00AMGlobeNewswire Inc.Independent Data Monitoring Committee Initiates process for Interim Analysis of Mesoblast’s Phase 3 Chronic Heart Failure ...NASDAQ:MESOMesoblast Limited
      03/27/20176:00AMGlobeNewswire Inc.Mesoblast Raises US$40 MillionNASDAQ:MESOMesoblast Limited
      03/20/20177:31AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      03/15/20176:00AMGlobeNewswire Inc.Durable Three-Year Outcomes In Degenerative Disc Disease After a Single Injection of Mesoblast’s Cell TherapyNASDAQ:MESOMesoblast Limited
      03/08/20176:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      03/07/20176:00AMGlobeNewswire Inc.FDA Grants Fast Track Designation for Mesoblast’s Cell Therapy in Children With Acute Graft Versus Host DiseaseNASDAQ:MESOMesoblast Limited
      02/28/20176:21AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      02/26/20175:07PMGlobeNewswire Inc.Mesoblast Presents Corporate Update and Financial Results for the Half Year Period Ended December 31, 2016NASDAQ:MESOMesoblast Limited
      02/24/20174:40PMGlobeNewswire Inc.Mesoblast to Host Second Quarter and First Half Financial Results Conference Call and WebcastNASDAQ:MESOMesoblast Limited
      02/17/20176:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      02/15/20174:54PMGlobeNewswire Inc.Durable Responses and Sustained Low Disease Activity Over Nine Months After a Single Dose of Mesoblast Cell Therapy in Rheuma...NASDAQ:MESOMesoblast Limited
      02/14/201712:12PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MESOMesoblast Limited
      02/14/201711:55AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MESOMesoblast Limited
      02/13/20175:31PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MESOMesoblast Limited
      02/13/20176:00AMGlobeNewswire Inc.Published Study Results Show That Mesoblast Cells Administered Intravenously Significantly Ameliorate Joint Disease in Model ...NASDAQ:MESOMesoblast Limited
      02/03/20176:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      01/31/20176:00AMGlobeNewswire Inc.Mesoblast Director Recognized by Peers for Cardiovascular LeadershipNASDAQ:MESOMesoblast Limited
      01/17/20176:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      01/12/20176:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      01/12/20176:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      01/11/20176:00AMGlobeNewswire Inc.Mesoblast to Present at 35th Annual J.P. Morgan Healthcare ConferenceNASDAQ:MESOMesoblast Limited
      01/09/20176:00AMGlobeNewswire Inc.Mesoblast Receives A$29.6 Million Following Share Issue to MallinckrodtNASDAQ:MESOMesoblast Limited
       Showing the most relevant articles for your search:NASDAQ:MESO

      Your Recent History

      LSE
      NESF
      Nextenergy Solar
      TSXV
      KNB
      LSE
      BN11
      Citi Fun 26
      Delayed Upgrade Clock